Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Mallinckrodt
AstraZeneca
Harvard Business School
McKinsey

Last Updated: June 28, 2022

Investigational Drug Information for Azacytidine


✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for Azacytidine?

Azacytidine is an investigational drug.

There have been 252 clinical trials for Azacytidine. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2019.

The most common disease conditions in clinical trials are Leukemia, Leukemia, Myeloid, Acute, and Leukemia, Myeloid. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and Celgene Corporation.

There is one US patent protecting this investigational drug and twenty-five international patents.

Recent Clinical Trials for Azacytidine
TitleSponsorPhase
Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial MalignanciesNational Cancer Institute (NCI)Phase 1/Phase 2
A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's LymphomaM.D. Anderson Cancer CenterPhase 2
A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic SyndroM.D. Anderson Cancer CenterPhase 2

See all Azacytidine clinical trials

Clinical Trial Summary for Azacytidine

Top disease conditions for Azacytidine
Top clinical trial sponsors for Azacytidine

See all Azacytidine clinical trials

US Patents for Azacytidine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Azacytidine See Plans and Pricing Heterocyclic compounds useful in the treatment of disease Epigen Biosciences, Inc. (San Diego, CA) See Plans and Pricing
Azacytidine See Plans and Pricing Heat shock protein 70 (hsp-70) receptor ligands Duke University (Durham, NC) See Plans and Pricing
Azacytidine See Plans and Pricing Peptides and combination of peptides for use in immunotherapy against various tumors IMMATICS BIOTECHNOLOGY GMBH (Tuebingen, DE) See Plans and Pricing
Azacytidine See Plans and Pricing Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus Seattle Genetics, Inc. (Bothell, WA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Azacytidine

Drugname Country Document Number Estimated Expiration Related US Patent
Azacytidine Canada CA2794266 2030-03-24 See Plans and Pricing
Azacytidine China CN103037690 2030-03-24 See Plans and Pricing
Azacytidine China CN105837411 2030-03-24 See Plans and Pricing
Azacytidine China CN110386876 2030-03-24 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Mallinckrodt
AstraZeneca
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.